| Autor: |
Koné M; Centre d'information pharmaco-thérapeutique de Bamako, Mali, Pharmacie Djenné, Torokorobougou, Bamako, Mali., Diallo T; Centre d'information pharmaco-thérapeutique de Bamako, Mali, Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali., Dénou A; Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali., Coulibaly BF; Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali, Pharmacie Soumba Konaté, Kéniéba, Mali., Dackouo B; Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali., Coulibaly B; Centre d'information pharmaco-thérapeutique de Bamako, Mali, Pharmacie de la Côte, Sogoniko, Bamako, Mali., Koumaré BY; Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali, Service contrôle qualité des médicaments, Laboratoire national de la santé, Bamako, Mali., Maiga A; Département des sciences du médicament, Faculté de pharmacie de Bamako, Mali. |
| Abstrakt: |
The aim of our study was to investigate the quality of information about pharmaceutical products in Mali. The study surveyed 98 prescribers, 60 pharmacists, and the package inserts of a basket of 30 generic medicines, compared to those of the corresponding proprietary versions. We made a rational choice of 98 doctors from various specialties and levels of the health system and randomly selected 60 of the 215 pharmacies in the district of Bamako (Mali). A rational sampling of generic medicines provided us with a basket of 30 drug notices for the antimalarial, antibiotic, antalgic, antipyretic, and anti-inflammatory agents used most in the Republic of Mali. This study showed that the pharmaceutical industry, through its sales representatives, are the main sources of drug information and that this information is not always adequate. The study also found that the content provided with generic medicines is sometimes different from the information for the proprietary brand-name drugs. |
